Source: Science Business
A bioengineering lab is receiving awards from National Institutes of Health to apply nanotechnology to treatments for breast cancer and diagnostics for deep vein blood clots. Both research programs are led by biomaterials professor Nicole Steinmetz at Case Western Reserve University medical school in Cleveland, Ohio.
The Steinmetz lab studies engineering at the molecular level to translate nanoscale molecular interactions into clinical applications, such as drug delivery and diagnostics. In their work, Steinmetz and colleagues identified potential cancer therapies in nanoscale viral particles shown to induce an immune response that overcomes solid tumor suppression of the immune system and combats the spread of cancer in the body.
Read more: http://sciencebusiness.technewslit.com/?p=31162